Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 4.830
+0.010 (0.21%)
Oct 14, 2026, 4:00 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of CAD 151.79 million as of October 14, 2026. It is the 24,849th most valuable company in the world and the 654th biggest in Canada. Its market cap has increased by 72.76% in one year.
Market Cap
151.79M
Enterprise Value
181.48M
Revenue
146.70M
Global Rank
Country Rank
#654 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 32.21M to 151.79M, an increase of 371.29%. That is a compound annual growth rate of 12.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 151.79M | 60.73% |
| Dec 31, 2025 | 94.44M | 10.49% |
| Dec 31, 2024 | 85.47M | 41.48% |
| Dec 29, 2023 | 60.41M | 45.19% |
| Dec 30, 2022 | 41.61M | -17.74% |
| Dec 31, 2021 | 50.58M | -48.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 341.28M |
| TerrAscend | 224.15M |
| Cardiol Therapeutics | 207.94M |
| Cannara Biotech | 205.33M |
| BioSyent | 193.95M |
| Organigram Global | 193.18M |
| Grown Rogue International | 142.47M |
| HLS Therapeutics | 124.51M |